Results 101 to 110 of about 786,579 (199)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy [PDF]

, 2021
Peiyan Zheng, Guanyu Yan, Yida Zhang, Huimin Huang, Wenting Luo, Mingshan Xue, Na Li, Jian‐Lin Wu, Baoqing Sun   +8 more
openalex   +1 more source

Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study)

Technology in Cancer Research & Treatment
Objective: The prognosis of malignant tumors with peritoneal metastases and cancerous ascites has generally been poor, with limited treatment options.
Yingying Xu MS, Yuehong Kong MS, Yifu Ma MS, Meiling Xu MS, Jiabao Yang MS, Junjun Zhang PhD, Rongzheng Chen MS, Guangqiang Chen MS, Zhihui Hong MS, Xiangrong Zhao MS, Chenyang Zhang MS, Pengfei Xing MS, Liyuan Zhang MD, Peifeng Zhao MS   +13 more
doaj   +1 more source

The antitumor mechanism of immuno-flap treatment in a rat model of head and neck cancer

Cancer Immunology, Immunotherapy
Background Local recurrence after surgical resection is a major clinical challenge in patients with advanced head and neck cancer (HNC). We previously reported using transfer of a flap treated with dendritic cells (DCs) (“immuno-flap”) as a novel cancer ...
Hiroaki Mori, Yasuto Akiyama, Chie Maeda, Akari Kanematsu, Tadashi Ashizawa, Kazue Yamashita, Haruo Miyata, Akira Iizuka, Tomoatsu Ikeya, Yoshichika Yasunaga, Jun Araki   +10 more
doaj   +1 more source

Characterization of Patients with Metastatic Non-Small-Cell Lung Cancer Obtaining Long-Term Benefit from Immunotherapy

, 2019
Giulia Galli, Claudia Proto, Diego Signorelli, Martina Imbimbo, Roberto Ferrara, Arsela Prelaj, Alessandro De Toma, Monica Ganzinelli, Nicoletta Zilembo, Filippo de Braud, Marina Chiara Garassino, Giuseppe Lo Russo   +11 more
openalex   +2 more sources

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy [PDF]

, 2022
Jinhui Liu, Yuanyuan Wang, Jian Yin, Yan Yang, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Mulong Du, Hao Yu, Jianling Bai   +10 more
openalex   +1 more source

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity [PDF]

, 2021
Himanshu Brahmbhatt, Jennifer A. MacDiarmid   +1 more
openalex   +1 more source

Survival of patients with unfavorable prognosis cutaneous melanoma with increased use of immunotherapy agents: a population‐based study in Belgium [PDF]

Diego Castanares‐Zapatero, Leen Verleye, Carl Devos, Nancy Thiry, Geert Silversmit, Nancy Van Damme, Cindy De Gendt, Frank Hulstaert, Mattias Neyt   +8 more
openalex   +1 more source

TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment

ImmunoTargets and Therapy
Veronika Švubová,1,2 Lucie Janstová,1 Marek Jedlička,1,2 Eva Mašínová,1,2 Jana Szabová,1 Tereza Feglarová,1 Kateřina Kuglerová,1 Veronika Bosáková,3,4 Barbora Brodská,1 Kristýna Boráková,5 David Kundrát,1 Iva Trsová,1,6 Martina ...
Švubová V, Janstová L, Jedlička M, Mašínová E, Szabová J, Feglarová T, Kuglerová K, Bosáková V, Brodská B, Boráková K, Kundrát D, Trsová I, Böhmová M, Kuželová K, Hrdý J, Gašová Z, Vydra J, Dostálová Merkerová M, Hortová-Kohoutková M, Frič J   +19 more
doaj  

Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide

, 1989
Eli Kedar, Revital Ben-Aziz, Eyal Epstein, Benny Leshem   +3 more
openalex   +2 more sources

Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma [PDF]

, 2022
Lingzhi Hong, Whitney E. Lewis, Monique B. Nilsson, Sonia Patel, Susan Varghese, Melvin J. Rivera, Robyn Du, Pingjun Chen, Haley N. Kemp, Waree Rinsurongkawong, Simon Heeke, Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrão, Boris Sepesi, Don L. Gibbons, J. Jack Lee, Jia Wu, Natalie I. Vokes, John V. Heymach, Jianjun Zhang, Xiuning Le   +21 more
openalex   +1 more source